28th Oct 2008 07:00
|
Press Release |
28 October 2008 |
LIDCO GROUP PLC
("LiDCO" or "the Company")
Duke University Health System submits US$250,000 order for LiDCO products
LiDCO, (AIM:LID) the hemodynamic monitoring company, is pleased to announce that, following a competitive evaluation, it has received a subsequent significant order from the Duke University Health System ("Duke"), North Carolina for US$250,000/£161,000.
This order of 12 monitors follows the successful installation of 16 monitors previously. The monitors include ten LiDCOplus and two of the recently introduced LiDCOrapid monitors. The hospital now has 28 LiDCO monitors in use in general and cardiac surgery and in a number of their intensive care departments.
Commenting on the order, Dr Terry O'Brien, CEO of LiDCO, said "Duke is a world-class provider of healthcare and one of the top ten hospitals in the USA. The order is further recognition of the quality of our products. We have worked closely with researchers at Duke for ten years, and we are delighted to have been able to secure a significant follow-on order from this important institution. Duke's role in educating future clinical and scientific leaders and their desire to advocate and practise evidence-based medicine make this a key reference centre for LiDCO. Duke is currently LiDCO's biggest customer in the USA."
- ENDS -
For more information please contact:
|
LiDCO Group Plc |
|
|
Terry O'Brien - Chief Executive John Rowland - Company Secretary |
Tel: +44 (0)20 7749 1500 |
|
www.LiDCO.com |
|
|
Panmure Gordon and Co |
|
|
Edward Farmer/ Katherine Roe |
+44 (0)20 7459 3600 |
|
www.panmure.com |
Media enquiries
|
Abchurch Communications |
|
|
Heather Salmond / Stephanie Cuthbert/Simone Alves |
0207 398 7718 |
|
www.abchurch-group.com |
About LiDCO Group Plc
LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com.
The Company's manufacturing facility is in Hoxton, London and its current products are:
* LiDCOplus and PulseCO monitors: these computer-based platforms are used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV% and SVV%)
* LiDCO disposables: used in conjunction with the LiDCOplus Monitor for accurate measurement of cardiac output in a minimally invasive manner
* LiDCOrapid : our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management in risk surgery patients
* LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus & rapid.
* LiDCOlive: a software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus or LiDCOrapid monitors
Related Shares:
LID.L